Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer.
Loading...
Embargo End Date
ICR Authors
Authors
Tree, AC
Dearnaley, DP
Dearnaley, DP
Document Type
Journal Article
Date
2020-03-01
Date Accepted
2019-09-20
Abstract
Evidence is accumulating for seven and less fractions in localised prostate cancer, including one large randomised trial. However, there is much more evidence yet to come and changing practice in advance of this may be premature. We review the reasons to persist with moderate hypofractionation for prostate cancer radiotherapy, until the results of further phase III studies are known.
Citation
Clinical oncology (Royal College of Radiologists (Great Britain)), 2020, 32 (3), pp. 175 - 180
Source Title
Publisher
ELSEVIER SCIENCE LONDON
ISSN
0936-6555
eISSN
1433-2981
Collections
Research Team
Clinical Academic Radiotherapy (Dearnaley)